Your browser doesn't support javascript.
loading
Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment.
Pépin, Marion; Ferreira, Ana Carina; Arici, Mustafa; Bachman, Maie; Barbieri, Michelangela; Bumblyte, Inga Arune; Carriazo, Sol; Delgado, Pilar; Garneata, Liliana; Giannakou, Konstantinos; Godefroy, Olivier; Grodzicki, Tomasz; Klimkowicz-Mrowiec, Aleksandra; Kurganaite, Justina; Liabeuf, Sophie; Mocanu, Carmen Antonia; Paolisso, Giuseppe; Spasovski, Goce; Vazelov, Evgueniy Stefanov; Viggiano, Davide; Zoccali, Carmine; Massy, Ziad A; Wiecek, Andrzej.
Afiliação
  • Pépin M; Paris-Saclay University, UVSQ, Inserm, Clinical Epidemiology Team, Centre de Recherche en Epidémiologie et Santé des Populations (CESP), Villejuif, France.
  • Ferreira AC; Department of Geriatrics, Ambroise Paré University Medical Center, APHP, Boulogne-Billancourt, France.
  • Arici M; Department of Nephrology, Centro Hospitalar e Universitário de Lisboa Central-Hospital Curry Cabral, Lisbon, Portugal.
  • Bachman M; Department of Nephology, Universidade Nova de Lisboa-Faculdade de Ciências Médicas, Lisbon, Portugal.
  • Barbieri M; Department of Internal Medicine, Division of Nephrology, Faculty of Medicine, Hacetepe University, Ankara, Turkey.
  • Bumblyte IA; Department of Health Technologies, School of Information Technologies, Tallinn University of Technology, Tallinn, Estonia.
  • Carriazo S; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Delgado P; Department of Nephrology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Garneata L; Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain.
  • Giannakou K; Department of Neurology, Vall d'Hebron Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain.
  • Godefroy O; Department of Internal Medicine and Nephrology, "Carol Davila" University of Medicine and Pharmacy, "Dr Carol Davila" Teaching Hospital of Nephrology, Bucharest, Romania.
  • Grodzicki T; Department of Health Sciences, School of Sciences, European University Cyprus, Nicosia, Cyprus.
  • Klimkowicz-Mrowiec A; Department of Neurology, Amiens University Hospital, and Laboratory of Functional Neurosciences (UR UPJV 4559), Jules Verne University of Picardie, Amiens, France.
  • Kurganaite J; Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Cracow, Poland.
  • Liabeuf S; Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Cracow, Poland.
  • Mocanu CA; Department of Nephrology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Paolisso G; Department of Pharmacology, Amiens University Medical Center, Amiens, France.
  • Spasovski G; MP3CV Laboratory, EA7517, University of Picardie Jules Verne, Amiens, France.
  • Vazelov ES; Department of Internal Medicine and Nephrology, "Carol Davila" University of Medicine and Pharmacy, "Dr Carol Davila" Teaching Hospital of Nephrology, Bucharest, Romania.
  • Viggiano D; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Zoccali C; Mediterranea Cardiocentro, Naples, Italy.
  • Massy ZA; Department of Nephrology, Clinical Centre "Mother Theresa", Saints Cyril and Methodius University, Skopje, North Macedonia.
  • Wiecek A; Dialysis Clinic of UMHAT "Alexandrovska", Sofia Medical University, Sofia, Bulgaria.
Nephrol Dial Transplant ; 37(Suppl 2): ii23-ii32, 2021 12 28.
Article em En | MEDLINE | ID: mdl-34718757
ABSTRACT
Neurocognitive disorders are frequent among chronic kidney disease (CKD) patients. Identifying and characterizing cognitive impairment (CI) can help to assess the ability of adherence to CKD risk reduction strategy, identify potentially reversible causes of cognitive decline, modify pharmacotherapy, educate the patient and caregiver and provide appropriate patient and caregiver support. Numerous factors are associated with the development and progression of CI in CKD patients and various conditions can influence the results of cognitive assessment in these patients. Here we review clinical warning signs that should lead to cognitive screening; conditions frequent in CKD at risk to interfere with cognitive testing or performance, including specificities of cognitive assessment in dialysis patients or after kidney transplantation; and available tests for screening and observed cognitive patterns in CKD patients.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Cognitivos / Insuficiência Renal Crônica Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Nephrol Dial Transplant Assunto da revista: NEFROLOGIA / TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Cognitivos / Insuficiência Renal Crônica Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Nephrol Dial Transplant Assunto da revista: NEFROLOGIA / TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França